Literature DB >> 6603311

The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid-like disease.

A Klajman, B Kafri, T Shohat, I Drucker, T Moalem, A Jaretzky.   

Abstract

Antibodies to histones were found to be most commonly responsible for the positive antinuclear antibody (ANA) test in asymptomatic patients treated with procainamide, in old people, in patients with neoplastic diseases, and in young women affected with a rheumatoid-like disease. Only in a very few patients were antibodies to dDNA and nucleoproteins demonstrated. Antibodies to nDNA were not found. The antibodies to histones were demonstrated by two methods: absorption of ANA-positive sera with a histone solution and subsequent performance of an ANA test; and acid elution of histones from thyroid sections followed by histone reconstitution.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603311     DOI: 10.1016/0090-1229(83)90050-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients.

Authors:  G C Astaldi Ricotti; M Pazzaglia; A M Martelli; A Cerino; M Bestagno; A Caprelli; S Riva; M A Pedrini; A Facchini
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

2.  Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.

Authors:  R L Rubin; S A Bell; R W Burlingame
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Procainamide elicits a selective autoantibody immune response.

Authors:  R L Rubin; G Reimer; E M McNally; S R Nusinow; R P Searles; E M Tan
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

4.  Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus.

Authors:  Xiao-Yun Sun; Jinxia Shi; Lei Han; Yin Su; Zhan-Guo Li
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.